What is Nebula Genomics?
Founded in 2018, Nebula Genomics operates at the intersection of consumer health and advanced R&D. The company distinguishes itself through a privacy-centric approach to DNA analysis, providing users with comprehensive insights into their ancestry, health predispositions, and lifestyle optimization. By leveraging high-fidelity sequencing technology, the firm serves a dual-market strategy, catering to individual consumers seeking personalized wellness data while simultaneously supporting business clients in the broader genomic research ecosystem. Its commitment to data security remains a core pillar of its market differentiation, positioning it as a trusted entity in an era of increasing digital health scrutiny.
How much funding has Nebula Genomics raised?
Nebula Genomics has raised a total of $150K across 1 funding round:
Debt
$150K
Debt (2020): $150K with participation from PPP
Key Investors in Nebula Genomics
PPP
Public-Private Partnership
What's next for Nebula Genomics?
Following this late-stage financing, Nebula Genomics is well-positioned to scale its operational capacity and expand its research initiatives. The capital will likely be deployed to enhance the efficiency of its sequencing pipelines and broaden its suite of personalized health analytics. As the company matures, the focus will shift toward deepening its integration within the clinical and research sectors, potentially unlocking new revenue streams through strategic partnerships. By maintaining its emphasis on privacy and data sovereignty, Nebula Genomics is poised to capture a larger share of the burgeoning personal genomics market, setting the stage for sustained growth and technological leadership in the years ahead.
See full Nebula Genomics company page
